American Oriental Bioengineering, Inc.
OTC: AOBI0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shujun Liu
- Employees
- 3,719
- Headquarters
- Beijing, China
- IPO year
- 2001
- Market cap
- $88.0
- Website
- http://www.bioaobo.com
Loading AOBI…
Loading profile data…Frequently asked questions about AOBI
What does American Oriental Bioengineering, Inc. (AOBI) do?
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian...
Where does AOBI trade?
American Oriental Bioengineering, Inc. (AOBI) trades on the Other OTC.
What sector is AOBI in?
American Oriental Bioengineering, Inc. (AOBI) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of American Oriental Bioengineering, Inc.?
Shujun Liu is the chief executive officer of American Oriental Bioengineering, Inc. (AOBI).
Where is American Oriental Bioengineering, Inc. headquartered?
American Oriental Bioengineering, Inc. is headquartered in China.
Does AOBI pay a dividend?
American Oriental Bioengineering, Inc. (AOBI) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AOBI go public?
American Oriental Bioengineering, Inc. (AOBI) completed its initial public offering in 2001.